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Abstract
Background: Newts have the remarkable ability to regenerate their spinal cords as adults. Their spinal cords
regenerate with the regenerating tail after tail amputation, as well as after a gap-inducing spinal cord injury (SCI),
such as a complete transection. While most studies on newt spinal cord regeneration have focused on events
occurring after tail amputation, less attention has been given to events occurring after an SCI, a context that is
more relevant to human SCI. Our goal was to use modern labeling and imaging techniques to observe axons
regenerating across a complete transection injury and determine how cells and the extracellular matrix in the
injury site might contribute to the regenerative process.
Results: We identify stages of axon regeneration following a spinal cord transection and find that axon regrowth
across the lesion appears to be enabled, in part, because meningeal cells and glia form a permissive environment
for axon regeneration. Meningeal and endothelial cells regenerate into the lesion first and are associated with a
loose extracellular matrix that allows axon growth cone migration. This matrix, paradoxically, consists of both
permissive and inhibitory proteins. Axons grow into the injury site next and are closely associated with meningeal
cells and glial processes extending from cell bodies surrounding the central canal. Later, ependymal tubes lined
with glia extend into the lesion as well. Finally, the meningeal cells, axons, and glia move as a unit to close the
gap in the spinal cord. After crossing the injury site, axons travel through white matter to reach synaptic targets,
and though ascending axons regenerate, sensory axons do not appear to be among them. This entire regenerative
process occurs even in the presence of an inflammatory response.
Conclusions: These data reveal, in detail, the cellular and extracellular events that occur during newt spinal cord
regeneration after a transection injury and uncover an important role for meningeal and glial cells in facilitating
axon regeneration. Given that these cell types interact to form inhibitory barriers in mammals, identifying the
mechanisms underlying their permissive behaviors in the newt will provide new insights for improving spinal cord
regeneration in mammals.
Background
Unlike mammals, adult newts have the remarkable abil-
i t yt or e c o v e rf u n c t i o na f t e rt h e ya r ep a r a l y z e db ya
spinal cord injury (SCI). After a complete transection
injury, newts regenerate their spinal cords and regain
use of their hindlimbs in as little as 4 weeks [1] (Addi-
tional file 1). This recovery requires supraspinal
axons to regenerate across the lesion and re-establish
connections with downstream targets and is not simply
due to a reorganization of circuits within the spinal cord
[1]. This finding led us to ask the question: why do
axons regenerate across an injury site in the newt when
they do not in mammals?
One of the main reasons why regeneration fails in
mammals is because the environment of the injured
spinal cord is inhibitory for axon regeneration [2]. After
an SCI, a variety of cell types, including astrocytes and
meningeal fibroblasts, react in ways that prevent axons
from regenerating across the injury site. These reactive
cells create physical barriers to regeneration, such as a
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any medium, provided the original work is properly cited.glial scar and a glia limitans at the border between the
cord and the injury site. They also create an extracellu-
lar matrix (ECM) that is inhibitory or repulsive for axon
growth cone migration.
Therefore, axon regeneration may be enabled in the
newt, in part, because the environment of the injury site
is not inhibitory. Cells may respond in ways that help
rather than hinder axon regeneration such that physical
barriers are not created and the ECM is not inhibitory.
Much of what is known about spinal cord regeneration
in salamanders comes from studies of tail regeneration.
After tail amputation, a blastema forms and ependymo-
glia (EG) lining the central canal of the spinal cord elon-
gate an ependymal tube that precedes and serves as
scaffold for axon regeneration [3]. Regeneration in this
context is thought to proceed as a recapitulation of devel-
opmental processes, and axons grow into newly develop-
ing tissues. Surprisingly, little is known about how axons
regenerate after an SCI in the newt. In this context,
axons must re-grow through an injury site having mature
tissues on both sides of the lesion. This context is more
relevant to the problem of spinal cord injury in humans.
Older studies of SCI in the newt have noted that a blas-
tema and glial scar do not appear to form [4], that axons
can bridge large gaps in the cord before ependymal tubes
elongate [5], and that, if left intact, the meninges can
serve as a scaffold for axon regeneration [6]. A more
recent study of SCI in the axolotl, a neotenic larval sala-
mander, found that EG appear to undergo an epithelial
to mesenchymal transition, migrate into the injury site to
form a solid mass, and then undergo a mesenchymal to
epithelial transition to re-form an ependymal tube that
serves as a scaffold for axon regeneration [7,8]. In sum-
mary, previous studies suggest that physical barriers do
not appear to form and EG and the meninges may help
axons regenerate. Although O’Hara et al.[ 7 ]d e m o n -
strated that mesenchymal cells in the axolotl injury site
were associated with fibronectin (FN), a permissive ECM
protein, little else is known about the nature of the ECM
of the injured newt spinal cord.
A focused and detailed study of axon regeneration and
the cellular and extracellular environment axons
encounter after an SCI in the newt has not been con-
ducted. We, therefore, took advantage of modern label-
ing and imaging techniques to define, for the first time,
stages of newt axon regeneration after a spinal cord
transection injury and find that meningeal cells and glia,
instead of interacting to form barriers to axon regenera-
tion as they do in mammals [9,10], appear to interact to
form a permissive environment for axon regeneration in
the newt. Our study examines many aspects of newt
spinal cord regeneration, establishes the required
foundation for further investigation into the cellular and
molecular mechanisms controlling this naturally occurring
process, and may inform new therapeutic approaches in
regenerative medicine.
Results and discussion
To understand how newt axons regenerate after an SCI
we carefully observed axons regenerating across a com-
plete transection injury, which severed all innervation to
the tail and hindlimbs. Animals were allowed to regen-
erate for 1 day, 3 days, 1 week, 2 weeks, 3 weeks,
4 weeks, 6 weeks or 9 weeks, and prior to tissue harvest
an axon tracer was applied rostral or caudal to the origi-
nal injury site in order to label descending or ascending
regenerating axons, respectively. The tracer and nuclei
were labeled fluorescently, and the injury site was ana-
lyzed in whole-mount preparation on a confocal micro-
scope. At least three animals were observed per tracer
application site and time point (Table 1).
Spinal cord transection injury and axon tracer application
The spinal column in Notophthalmus viridescens con-
tains one cervical (the atlas), about 13 trunk, 1 to 2
sacral, and 22 to 25 caudal vertebrae (Figure 1A) [11].
The numbers of trunk, sacral and caudal vertebrae
appear to be variable. The hindlimbs are innervated pri-
marily by the last two trunk (T-1 and T-2) and first
sacral (S1) spinal nerves, though there can be contribu-
tions from the third to last trunk (T-3) vertebra and the
vertebra after S1 (S2/C1) (Figure 1D) [11]. This is sup-
ported by the fact that the largest spinal nerves are asso-
ciated with T-2, T-1 and S (Additional file 2) and axon
tracer applied to the sciatic nerve labels primarily neu-
rons in these spinal ganglia. To be sure all innervation
to the hindlimbs was severed, we aimed to transect the
spinal cord between T-4 and T-3 (Figure 1A, D), about
1 cm rostral to the hindlimbs. Upon dissection, it was
often found that the injury was actually one or two seg-
ments rostral to the targeted site (Additional file 2B).
Figure 1B shows what the intact spinal cord looks like
when exposed from the dorsal side. After a complete
transection injury, the two ends of the cut cord spring
away from each other leaving a gap in the cord
(Figure 1C). This type of injury was chosen because it is
simple to perform consistently, spares no axons, severs
the meninges as well as axons, and allows our studies to
more seamlessly complement those done by previous
investigators [1,4,12]. All injured animals were paralyzed
and unable to swim for at least 3 weeks (Additional
file 1), though the typical reflexive movements of the
hindlimbs and tail were observed. Recovery of swim-
ming function was scored and filmed in 6- and 9-week
regenerates. One out of seven (14%) 6-week regenerates
and four out of six (67%) 9-week regenerates recovered
swimming function (Table 1). This recovery rate is
consistent with that reported in Davis et al. [1].
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foam saturated with the axon tracer biotinylated dextran
amine (BDA) was inserted into a transection injury 1
segment (about 2 mm) rostral to the original injury
site (Figure 1D), and the tracer was allowed to travel for
6 hours. Ascending axons were similarly labeled by
applying the tracer one segment caudal to the original
injury. BDA travels 3 to 4 mm in 6 hours (Figure 2K,
L), produces a strong signal, and labels only neurons
and their processes in the nervous system (Figure 1E). It
does not diffuse across an injury site to label axons that
have not regenerated across it (Figure 2A-D). Transect-
ing the spinal cord to apply the tracer rostral or caudal
to the original injury site 6 to 24 hours prior to tissue
harvest does not appear to alter the general appearance
of axons in the injury site (compare Figure 1F and 1G).
Stages of axon regeneration
Our tracer analyses uncovered six stages of axon regen-
eration that appeared to be typical and sequential
(Figure 2). The timing for all but the first two stages
was highly variable (Table 1). This variability is likely
due to differences in the age, size, health and activity
level of the animals as well as the size of the gap in the
cord and not due to differences in the completeness of
the transection injury. It was quite easy to completely
transect the newt spinal cord and visually confirm that
the transection was complete (Figure 1C). The adult
newts used in this study were collected from the wild
and their ages are unknown. As noted below, the size of
the gap in the cord tended to increase before it
decreased, perhaps because of body movements of the
animal. The times in parentheses after each stage indi-
cate the earliest and latest time points at which the
stage was observed.
Retraction stage (1 day to 1 week, most often before 1
week)
Axons appear to have retracted away from the end of
the cut cord (Figure 2A, B), and many axon tips have a
balled-up morphology that is reminiscent of the dys-
trophic end-bulbs seen on axons that are unable to
regenerate (Figure 2B”) [13,14]. Axon growth cones,
however, can also be identified at this stage (Figure 2B’).
Growth initiation stage (3 days to 2 weeks, most often
at 1 week)
Axons appear to have initiated growth and grown back
to the end of the cut cord (Figure 2C, D). As in the
retraction stage, dystrophic axons and growth cones can
be identified (Figure 2D’,D ”). The main difference
between the first two stages is that many more axons
extend to the end of the cut cord in the growth initia-
tion stage. This difference is apparent even when all
axons from the spinal cord are viewed in z-projections
(Additional file 3). Also in this stage, the central canal,
especially on the rostral side, begins to enlarge to form
the terminal vesicle (TV).
Wrapping stage (2 weeks to 4 weeks)
Axons continue to grow and wrap around the end of
the TV (Figure 2E, F). Residual numbers of dystrophic
axons can still be seen at this and all subsequent stages.
The meninges also wrap around, or bound, the end of
the cord (Figure 2E, F) and often begin regenerating
a c r o s st h ei n j u r ys i t ea h e a do ft h ea x o n sa n dT V
(Figure 2F). The low density of cells within the injury
site suggests that a scar is not forming. The size of the
gap in the cord is also larger at this stage than at all
other stages (Additional file 4). This could indicate that
the wrapping stage is an abortive stage seen only in ani-
mals that do not recover function. We do not favor this
interpretation, however, because wrapping axons are still
Table 1 The number of animals observed at each stage and time point
Time
point
Total Retraction Growth
initiation
Wrapping Wrapping/
wisping
Wisping Wisping/
spiking
(no ET)
Spiking
(no ET)
Spiking
(with
ET)
Contact Growth
beyond
injury (not
recovered)
Growth
beyond
injury
(recovered)
1 day 6 (3/3) 6 (3/3)
3 day 8 (4/4) 6 (4/2) 2 (-/2)
1 week 15 (11/4) 3 (3/-) 12 (8/4)
2 week 11 (6/5) 2 (1/1) 3 (1/2) 2 (1/1) 4 (3/1)
3 week 10 (5/5) 2 (2/-) 4 (-/4) 1 (1/-) 1 (1/-) 2 (1/1)
4 week 8 (4/4) 4 (3/1) 1 (1/-) 3 (-/3)
6 week 7 (4/3) 1 (-/1) 1 (-/1) 1 (-/1) 2 (2/-) 1 (1/-) 1 (1/-)
9 week 6 (4/2) 2 (1/1) 4 (3/1)
Totals 71 (41/30) 15 (10/5) 16 (9/7) 9 (6/3) 2 (1/1) 9 (3/6) 1 (-/1) 1 (-/1) 4 (4/-) 2 (2/-) 7 (2/5) 5 (4/1)
The numbers in parentheses break the totals for each category into rostral and caudal tracer application, respectively. For example, (4/2) indicates 4 animals
received rostral tracer and 2 received caudal tracer. Animals that had recovered function were chosen preferentially for rostral tracer application. ET, ependymal
tube.
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and growth beyond stage. This suggests that wrapping is
a typical stage through which all regenerating spinal
cords progress. The gap in the cord may get bigger
before it gets smaller, simply as a result of body move-
ments of the animal.
Wisping stage (2 weeks to 6 weeks)
Axons begin growing, or wisping, into the injury site
ahead of the EG-lined TV (Figure 2G, H). Thus, as seen
in previous studies of SCI in the newt, a pre-formed
ependymal tube is not required for axon regeneration
into the injury site [5,6]. Wisping axons, however, do
not grow into the ECM of the injury site alone but
rather remain associated with cells. Many of these cells
appear to be continuous with the meninges. At this
stage, the meninges do not bound the end of the cord
as they did in the wrapping stage but continue regener-
ating across the injury site, preceding the regenerating
axons. Some wisping axons even appear to follow the
regenerating meninges (Additional file 5).
Spiking stage (3 weeks to 6 weeks)
As wisping axons continue to grow, they may fasciculate
to form a spike (Figure 2I, J; Additional files 6 and 7).
Spiking axons are still associated with cells in the injury
Figure 1 Spinal cord transection injury and axon tracer application. (A) Newt skeleton showing targeted location of injury. Note, the
sacroiliac (SI) joints are not associated with the same vertebra in this animal, thus there are two sacral (S) vertebrae where there is usually one.
T, trunk; C, caudal. (B) Intact and (C) completely transected spinal cord viewed from dorsal side. (D) Cartoon showing the location of the
targeted injury, the spinal ganglia that supply innervation to the hindlimbs (solid line, primary contribution; dotted line, occasional contribution),
and rostral tracer application site. (E) Cross-section of spinal cord about 500 μm away from a tracer application site showing the tracer labels
axons and neurons specifically. (F, G) Longitudinal sections through 1-week regenerates. Asterisk, injury site. The tracer was applied to the animal
in (F) and not to the animal in (G). Axons were also labeled with the 3A10 antibody. Application of the tracer 6 hours prior to tissue harvest did
not alter the overall appearance of the axons at the injury site. cc, central canal; eg, ependymoglia; gm, grey matter; wm, white matter; m,
meninges; D, dorsal; V, ventral; R, rostral; C, caudal. Scale bars: 200 μm ((F) and (G) are the same scale).
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Rostral is to the left. Descending (A, C, E, G, I, K) or ascending (B, D, F, H, J, L) axons were labeled with the axon tracer (magenta), and nuclei are
shown in green. Time after injury is indicated in the upper right corner of each panel. (A, B) Retraction and (C, D) growth initiation stages.
Arrowheads, end of cord; asterisk, injury site; dotted line, unlabeled cord opposite the injury site. (B) is a z-projection of four planes to highlight
growth cones. (B
’,B
“,D
’,D
“) Enlargements of dotted boxes in (B) and (D) showing that growth cones (primed boxes) and dystrophic axons
(double primed boxes) are present at both stages. (E, F) Wrapping stage. (G, H) Wisping stage. (I, J) Spiking stage. (H) and (I) are z-projections
of two confocal planes to show wrapping axons with wisping (H) or spiking (I) axons. (K, L) Contact and growth beyond the injury site stage.
The animal in (K) had recovered swimming function, while the one in (L) had not. Open arrowheads, residual wrapping axons; arrows, meninges.
TV, terminal vesicle; R, rostral; C, caudal. Scale bars: 200 μm (A-L); 50 μm( B ’,B ”,D ’,D ”).
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Some spikes do not contain an ependymal tube
(Figure 2J), while others do (Figure 2I). In spikes with
an ependymal tube, the ependymal tube appears to have
elongated from the end of the cut cord because the lar-
gest part of the TV and residual wrapping axons are
seen well behind the tip of the spike (Figure 2I; Addi-
tional file 7). It is conceivable that a spike may not need
to form. For example, if the gap in the cord is not large,
wisping axons may be able to grow through the lesion
and enter the cord on the opposite side without forming
a spike.
Contact and growth beyond the injury site stage (3 weeks
to 9 weeks)
In this stage, the two ends of the cord make contact
with each other, and axons begin growing through the
c o r do nt h eo p p o s i t es i d eo ft he injury to re-establish
functional connections (Figure 2K, L). All animals that
had recovered swimming ability were in this stage,
although not all animals in this stage had recovered
function. Also, in all animals that had recovered, the
ependymal tubes on each side of the injury had fused
together to re-establish a continuous central canal. It
was not possible to correlate the distance axons had
regenerated beyond the injury site with functional
recovery in this study because the axon tracer appears
to fade out after 3 to 4 mm (Figure 2K, L). This is
true even in the intact spinal cord (data not shown).
There is some tolerance for sloppiness in how axons
regenerate, for even in animals that had recovered
function, wrapping axons were still evident (Additional
files 8A and 9), some axons appeared to decussate
(Additional files 8A’ and 9), and separate fiber tracts
could be seen traveling along the meninges (Figure
2K). It would be interesting to determine whether
these aberrant axon trajectories are pruned or refined
over time in animals that have been allowed to regen-
erate for longer than 9 weeks. Excessive sloppiness or
gross misalignments may be the cause of a delay in or
ac o m p l e t ef a i l u r eo ff u n c t i onal recovery (Additional
files 8B-F and 10).
Sensory axons do not appear to regenerate
Descending and ascending regenerating axons appear to
progress through similar stages (Table 1; Additional file
11). This was surprising given that sensory axons are
not thought to regenerate after an SCI in newts or zeb-
rafish even though these animals recover function
[6,15]. To determine if ascending regenerating axons are
true sensory axons, rather than axons arising from neu-
rons within the spinal cord, an axon tracer was applied
to the sciatic nerve 1 or 4 days prior to tissue harvest
(Figure 3A). In 6-week regenerates, descending axons
were also labeled with a different tracer. Our goal was
to identify tracer-labeled sensory axons wisping into and
growing through and beyond the lesion.
Tracer application to the sciatic nerve effectively labels,
on the ipsilateral side only, sensory neurons in the
spinal ganglia, motor neurons, dorsal column axons, and
occasionally axons in a ventral location, which are pre-
sumably motor neuron axons exiting the cord to form
the ventral root (Figure 3B). Labeled sensory and motor
neurons were found mostly at the level of S1 and T-1
and occasionally at T-2 (Figure 3A).
To determine if sensory axons are among axons wisp-
ing into the injury site, 3-week regenerates received tra-
cer application to the sciatic nerve 4 days prior to tissue
harvest (n = 3). The spinal cord caudal to the injury site
(T-2 to S1) was analyzed in cross-section to determine
the effectiveness of the tracer application. Sensory and
motor neurons and dorsal column axons were labeled in
all three animals (Figure 3C). The injury site was ana-
lyzed in longitudinal sections to best view wisping
axons. In sections through the dorsal columns, tracer-
labeled sensory axons could be seen all the way up to
the end of the cut cord (n = 2 out of 3; Figure 3D). In
ventral sections through the region of wisping axons,
however, none of the wisping axons were labeled with
the tracer (Figure 3E).
To determine if sensory axons grow through and
beyond an injury site, 6-week regenerates received rho-
damine dextran amine (RDA) application to the sciatic
nerve 4 days prior to tissue harvest. BDA was also used
to label descending axons. The spinal cord caudal to the
lesion and the lesion itself were analyzed in cross-
section (n = 4). Sensory and motor neurons and dorsal
column axons were effectively labeled with RDA in the
spinal cord caudal to the lesion in three out of the four
animals (Figure 3F). Two of the animals in which RDA
was effectively applied had recovered function, and
BDA-labeled descending axons could be seen growing
through and at least 500 μm caudal to the injury site
(Figure 3G, H). Despite this, RDA labeling in dorsal col-
umn axons got progressively weaker towards the injury,
and RDA-labeled dorsal column axons were never seen
in the injury site in any animal (Figure 3G, H).
We were not able to detect tracer-labeled sensory
axons wisping into the lesion and growing through or
beyond the lesion. This could indicate that sensory
axons are either delayed or not regenerating or that the
tracer faded out before the injury site. The tracer
appears to travel a sufficient distance in four days to
label wisping axons because it was seen robustly in
dorsal column axons all the way up to the injury site in
3-week regenerates (Figure 3D). If the axons had regen-
erated, however, it is possible that the tracer was not
detected in the injury site because of a dilution effect.
The most likely explanation for why the tracer faded in
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the dorsal column axons were degenerating [6]. There-
fore, sensory information may not be needed for func-
tional recovery in the newt, or sensory information may
be transmitted to the brain via a relay circuit that is
formed by ascending propriospinal axons that do regen-
erate across the injury site.
Axons regenerate through white matter to reach
functional targets
Axons regenerating beyond the injury site in zebrafish
travel preferentially through the grey matter rather
than white matter to reach functional targets [16]. Our
initial study of axon regeneration in whole-mount pre-
parations suggested that this is not true in newts
Figure 3 Sensory axons may not regenerate.( A) Cartoon showing tracer application sites in relationship to the SCI. Tracer was applied to the
sciatic nerve in the hindlimb to label sensory axons (green) and, in 6-week regenerates, rostral to the injury to label descending axons
(magenta). Tracer applied to the sciatic nerve labels primarily neurons in spinal ganglia S1 and T-1 (solid lines) and occasionally neurons in T-2
(dotted lines). (B) Cross-section through spinal cord and spinal ganglia at T-1, 1 day after SCI and tracer application to the sciatic nerve. The
tracer labels sensory neurons in the spinal ganglia (sg), motor neurons (mn), dorsal column axons (dc), and motor neuron axons (mna) exiting to
form the ventral root. (C-E) Sections through a 3-week regenerate. Sensory axons were labeled with biotinylated dextran amine (BDA; green),
and all axons were labeled with 3A10 (magenta in (D, E)). (C) Cross-section at T-1. Inset, spinal ganglia on labeled side. (D, E) Longitudinal
sections through the SCI at the level of the dorsal columns (D), and a more ventral level where there are wisping axons (E). Schematic cross-
sections of the spinal cord in the upper right corner show where the section is along the D-V axis. (F-H) Cross-sections through a 6-week
regenerate that had recovered swimming function at T-1 (F), at T-4, about 500 μm caudal to the SCI (G), and through the center of the SCI at
T-4/T-5 (H). Sensory axons were labeled with rhodamine dextran amine (RDA; green), and descending axons were labeled with BDA (magenta).
Inset in (F), spinal ganglia on labeled side. Inset in (H), phase image of injury site. Nuclei are shown in blue. D, dorsal; V, ventral; R, rostral; C,
caudal. All scale bars: 200 μm ((C-H) are the same scale; insets in (C, F) are the same scale).
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axons in three 6-week regenerates in the growth
beyond the injury site stage were analyzed in cross-
section about 500 μm caudal to the injury site. All
axons in all three animals traveled in the white matter
only (Figure 3G). Thus, axons do not re-route through
the grey matter to reach functional targets in the newt.
This suggests that white matter inhibitors [17] either
are not present in the newt spinal cord during axon
regeneration or that newt axon regrowth is not inhib-
ited by these molecules.
Extracellular matrix of the injured newt spinal cord
The ECM associated with an SCI in mammals is inhibi-
tory or repulsive for axon growth cone migration [2].
Chondroitin sulfate proteoglycans (CSPGs) are a major
component of this inhibitory ECM. After injury, they are
expressed by a variety of cell types, including astrocytes
and meningeal cells, and they are expressed in the glial
scar and glia limitans that forms at the border between
the injury site and the spinal cord. They are also upregu-
lated in the spinal cord itself in a gradient that increases
as axons approach the injury site [18,19]. ECM proteins
that are canonically permissive for growth cone migra-
tion, such as FN [10,20], laminin (LM) [21] and collagen
(Col) [22], as well as ECM proteins with more ambiguous
effects, such as tenascin C (TN-C) [18], are also
expressed. Overall, however, the ECM is dense and does
not support growth cone motility [23,24].
Axon regeneration in the newt, then, may be enabled,
in part, because the ECM of the injured newt spinal
cord is not inhibitory. Consistent with previous studies,
our initial axon regeneration experiments suggest that a
dense scar does not form in the lesion (Figure 2E-J). To
confirm this observation and determine if the ECM in
the newt contains permissive rather than inhibitory pro-
teins, we used immunohistofluorescence to analyze the
expression of CSPGs, TN-C, FN, LM, and Col in wisp-
ing and spiking stage regenerates, the stages in which
axons grow across the injury site. We used 2.5- to
3-week regenerates to target these stages (Additional file
11), and axons were labeled either with the axon tracer
or an antibody against neurofilament associated protein
(3A10).
In the intact spinal cord, CSPGs are not expressed,
though they are expressed in the vertebral body in asso-
ciation with chondrocytes (Figure 4A). Surprisingly,
CSPGs are expressed in the injured newt spinal cord.
They are associated with the meninges and blood vessels
(Figure 4B, C) and are expressed near wisping axons
(Figure 4B, D). CSPGs are not found in the grey or
white matter of the injured spinal cord and do not form
a barrier between the cord and injury site. Thus, astro-
cytes in the spinal cord do not appear to express
CSPGs. CSPGs also do not form a dense scar within the
lesion.
Unlike CSPGs, TN-C, FN, Col, and LM are expressed
in the intact cord in association with the meninges and
blood vessels (Figure 4E, I, M, Q). After injury all of
these proteins are expressed in a pattern similar to
CSPGs. They are associated with the meninges and
blood vessels (Figure 4F, G, J, K, N, O, R, S) and are
expressed near wisping axons (Figure 4F, H, J, L, N, P,
R, T). These proteins are not found in the grey or white
matter of the injured spinal cord, do not form a barrier
between the cord and injury site, and do not form a
dense scar within the injury site. We occasionally
detected a weak TN-C signal within the white matter of
the spinal cord, but this signal was not significantly
above background noise (autofluorescence and non-
specific staining). A previous study detected a stronger
TN-C signal in the white matter of the intact and regen-
erating newt tail spinal cord [25]. We were unable to
reproduce these results, perhaps because we were ana-
lyzing a different region of the spinal cord, a different
regenerative context, or TN-C expression with different
TN-C antibodies.
In summary, similar inhibitory and permissive ECM
proteins are expressed in the injured newt and mam-
malian spinal cords, but the pattern of expression is
different. In the newt, the ECM associated with wisp-
ing axons is loose and open, and a dense scar does not
form. Also, ECM proteins are not present within the
grey or white matter of the spinal cord, and the ECM
does not form a permanent barrier, or glia limitans,
b e t w e e nt h ec o r da n dt h ei n j u r ys i t e ,t h o u g hw ed o
have preliminary evidence that such a barrier may
exist transiently during the wrapping stage (Additional
file 12). Overall, even though inhibitory CSPGs are
expressed, the ECM of the injured newt spinal cord
does appear to be more permissive for axon growth
cone migration than that of the injured mammalian
spinal cord.
Meningeal and endothelial cells are associated with
wisping axons
Given that cells closely associated with axons growing
across the injury site and cells that create the permissive
ECM are likely to be playing an important role in
enabling axon regeneration, we sought to identify these
cells. We hypothesized that they may be meningeal and/
or endothelial cells because, in the intact and regenerat-
ing spinal cord, ECM appears to be expressed by cells of
the meninges and blood vessels, not by cells in the grey
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Page 8 of 22Figure 4 Wisping axons are associated with loose ECM made up of canonically inhibitory and permissive proteins. Axons were labeled
with 3A10 (B-D, G-H, S-T, V) or the axon tracer (F, J-L, N-P, R) and are shown in magenta. Each ECM protein is shown in green, and nuclei are
blue. (A-D) Chondroitin sulfate proteoglycan (CSPG) expression in the intact spinal cord (A, cross-section) and in wisping stage regenerates (B-D).
(B) is a longitudinal section. (C) and (D) are cross-sections through the terminal vesicle (C), and axons wisping into the injury site (D) from the
same animal. Schematic longitudinal sections of the spinal cord in the upper right corner of (C) and (D) show where the section is in
relationship to the injury site. (E-V) Similarly, the expression of tenascin-C (E-H), FN (I-L), Collagen XII (M-P), laminin (Q-T), and pigment (U, V) is
shown. (W) A section adjacent to the one shown in (B) treated with chondroitinase ABC (chABC) before incubation with the CS-56 antibody.
(X) A section adjacent to the one shown in (E) treated only with secondary antibody; the primary antibody was omitted. D, dorsal; V, ventral; R,
rostral; C, caudal. Scale bar: 200 μm (A-X).
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the spinal cord do not appear to express ECM, at least
not around their cell bodies. Our hypothesis is also sup-
ported by the fact that in the intact spinal cord, pigmen-
ted cells are only found in the meninges and blood
vessels (Figure 4U), and pigmented cells are associated
with wisping axons (Figure 4V). Additionally, many cells
associated with wisping axons appear to be meningeal
cells because they are continuous with the meninges
(Figure 2). The meninges appear to regenerate ahead of
regrowing axons, and some regrowing axons even
appear to follow the regenerating meninges (Figure 5D;
Additional file 5).
To determine if cells associated with wisping axons
and ECM are endothelial cells, we used the endothelial
cell marker von Willebrand Factor (vWF), which
appears to specifically label blood vessels in the newt
spinal cord (Figure 5A). In wisping stage regenerates,
vWF+ cells can be found in the injury site and near
(Figure 5B, B”) and ahead of (not shown) regenerating
axons. These cells are also associated with FN, though
not all of the FN is associated with vWF+ cells (Figure
5B, B’,B ”). It has been hypothesized that blood vessels
and nerves, because of their close proximity and paral-
lel tracts, guide each other during development [26].
To determine whether they might guide one another
during newt spinal cord regeneration, we analyzed
injury sites in cross-sections. We found that though
vWF
+ cells and axons are in the injury site at the same
time, they do not need to be in direct contact with
each other (Figure 5C). Therefore, regenerating blood
vessels and axons do not appear to guide one another
across the injury site, at least not through a contact-
mediated mechanism.
Many cells in the injury site were not vWF
+,a n d
much of the FN was not associated with vWF
+ cells.
We, therefore, sought to determine, more conclusively,
if any of the cells closely associated with wisping axons
and ECM were meningeal cells. Meningeal cell markers
such as retinaldehyde dehydrogenase 2 (RALDH2) and
NG2 [27] did not produce a signal in our preparations
(Additional file 13) so we used electron microscopy
(EM) to analyze cell types based on ultrastructure. In
the intact and regenerating spinal cords, meningeal cells,
in general, have an electron-dense cytoplasm filled with
mitochondria, an elongated nucleus with some clumped
chromatin, and thin dark processes that are often asso-
ciated with ECM (Figure 5E, F; Additional file 14). None
of the other cell types in the intact cord shared these
characteristics of meningeal cells (compare Additional
files 14 and 15). In regenerating spinal cords, we
observed cells with meningeal cell characteristics closely
associated with regrowing axons. Figure 5H shows an
enlargement of one of these cells. It has an electron
dense cytoplasm filled with mitochondria, an elongated
nucleus with some clumped chromatin, and thin dark
processes that appear to wrap around a bundle of axons
that has been cut in cross-section. Processes from this
cell are also associated with ECM (Figure 5I). Another
meningeal-like cell (Figure 5G) was associated with dura
mater-like elements, namely ECM and fine, dark cell
processes (Additional file 14B). Processes from the cell
in Figure 5G form a closed loop, which suggests they
may be attempting to wrap or cup around structures in
their environment.
It is difficult to know with certainty the identity of the
meningeal-like cells. Stensaas [6] suggested that cells
with these characteristics were dark astrocytes derived
from EG. Morphologically, however, these cells and their
processes resemble meningeal cells far more than they do
EG and astrocytes (Additional files 15 and 16). Although
these cells appear to wrap around axons, we and Stensaas
[6] saw no evidence of them forming myelin, and there-
fore we do not think they are oligodendrocytes or
Schwann cells. Further support for the idea that these
cells may be meningeal cells comes from studies of
meningeal cells that are transplanted into injured mam-
malian spinal cords along with olfactory ensheathing
cells (OECs). Such meningeal cells appear to wrap axons
into fascicles much like fibroblasts in the perineurium of
peripheral nerves wrap axons [28,29]. These meningeal
cells were also associated with ECM and had morpholo-
gical features similar to our meningeal-like cells.
Ependymoglial and astrocytic processes are associated
with wisping axons
As mentioned above, axonsa r eo f t e ns e e nw i s p i n g
ahead of the central canal, and thus, a pre-formed epen-
dymal tube is not required for axon regeneration after
an SCI. To determine if EG still might be playing a role
in axon regrowth, we used an antibody against glial
fibrillary acid protein (GFAP). In the intact newt spinal
cord, GFAP weakly labels EG cell bodies, strongly labels
astrocytic cell bodies and strongly labels radial processes
from both these cell types (Figure 6A). Therefore, this
cell marker enabled us to observe the astrocytic as well
as EG response.
In the injured spinal cord, GFAP expression is main-
tained in astrocytes and EG around the central canal. It
does not appear to be upregulated, and GFAP
+ pro-
cesses do not appear to be thicker than they are in the
intact cord (compare Figure 6A and 6B). Therefore,
astrocytes do not appear to become hypertrophic. In the
injury site, only a few GFAP
+ cell bodies can be found
(Figure 6D, D’). These cells are more likely to be EG
than astrocytes because they express GFAP only weakly.
Thus, astrocytes do not migrate into the lesion. In wisp-
ing stage regenerates, GFAP
+ processes are closely
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Page 10 of 22Figure 5 Meningeal and endothelial cells are associated with wisping axons. (A-D) Axons were labeled with the axon tracer (B, C) or 3A10
(D) and are shown in magenta, von Willeband factor (vWF) is green (A-C) and nuclei are blue. (A) Cross-section through intact spinal cord.
(B) Longitudinal section through the SCI of a wisping stage regenerate labeled with anti-FN (white, shown separately in (B’)) and anti-vWF
(green, shown separately in (B”)). Arrowheads, cells double-labeled with FN and vWF. (C) Cross-section through axons wisping into the injury site
of a wisping stage regenerate. Schematic longitudinal section of the spinal cord in the upper right corner shows where the section is in
relationship to the injury site. (D) Single confocal plane of a longitudinal thick section of a wisping/spiking stage regenerate. Arrowhead,
meninges (m). (E-I) Longitudinal section through a wisping stage regenerate imaged with electron microscopy. (E) Region containing axons
wisping ahead of the TV. Asterisks, phagocytic cells. (F) Enlargement of meningeal cells in box F of (E). (G) Enlargement of meningeal-like cell in
box G of (E) that is associated with dura mater ECM (ecm). Arrowhead, closed loop formed by meningeal-like cell processes; arrow, process
resembling dura mater cell process. (H) Enlargement of meningeal-like cell in box H of (E), rotated 90°. This cell’s processes (arrowheads) wrap
around a bundle of axons (ax) cut in cross-section. (I) Enlargement of box I in (H) showing that this cell’s processes (arrowheads) are also
associated with ECM (ecm). D, dorsal; V, ventral; R, rostral; C, caudal. Scale bars: 200 μm (A-D); 50 μm (E); 10 μm (F-H); 1 μm (I).
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processes likely originate from EG and astrocytes that
surround the central canal. Rather than being aligned
perpendicular to axons, as they are during tail regenera-
tion, however, the GFAP
+ processes are aligned more
parallel to the direction in which axons travel. This is
especially evident in later-stage regenerates (Figure 6E).
Note also that the GFAP
+ processes do not form a glia
limitans between the cord and the injury site as they do
in mammals (Figure 6B, D).
These data demonstrate that, while the EG response
after SCI appears to be different to that after tail ampu-
tation, EG are still likely to be playing an important role
in enabling axon regeneration because GFAP
+ processes
are closely associated with axons growing across the
injury site. Also, while EG do not appear to migrate into
Figure 6 Glial processes are associated with wisping axons and do not form inhibitory barriers. Axons were labeled with 3A10 (B, D) or
the axon tracer (E) and are shown in magenta. Glia were labeled with anti-GFAP (green), and nuclei are blue (A-D). (A) Cross-section through
intact spinal cord. GFAP labels EG and astrocytes and all of their processes. (B) Longitudinal section through the SCI of a wisping stage
regenerate. Astrocytes do not become hypertrophic (compare with (A)). (C) Section adjacent to (B) treated only with secondary antibodies;
primary antibodies were omitted. (D) Longitudinal section through the SCI of a wisping stage regenerate. (D’) Enlargement of dotted box in (D).
GFAP
+ processes (arrows) are associated with wisping axons and do not form a glia limitans. Only a few weakly GFAP
+ cells (arrowhead) are in
the injury site. (E) Single confocal plane of a longitudinal thick section of a growth beyond stage regenerate. GFAP
+ processes run parallel to
axons across the injury site. D, dorsal; V, ventral; R, rostral; C, caudal. Scale bars: 200 μm (A-D; (B) and (C) are the same scale; (D) and (E) are the
same scale); 50 μm( D ’).
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appear to do so.
Furthermore, the astrocytic response in the newt is
very much different to that seen in mammals. Newt
astrocytes do not appear to become hypertrophic,
migrate into the injury site, express ECM, or form a glia
limitans or scar. Instead of inhibiting axon regeneration
as they do in mammals, newt astrocytes may, like EG,
play a supportive role because many of the GFAP
+ pro-
cesses associated with axons likely arise from astrocytes
as well as EG.
An inflammatory response is present but does not appear
to be detrimental to regeneration
It has been hypothesized that inflammation leads to
scarring and non-regenerative wound healing and that it
is not present in systems that regenerate [30]. In sup-
port of this, macrophages in the injured mammalian
spinal cord contribute to the formation of the scar [31]
and have even been shown to physically interact with
axons to cause retraction [32].
To determine if an inflammatory response might be
present in the newt SCI, we used H&E staining. With
H&E staining, an inflammatory response is character-
ized by the appearance of many small round cells that
have dark blue nuclei and very little cytoplasm. Lym-
phocytes have almost no cytoplasm, whereas monocytes
have a small rim of cytoplasm. Based on these charac-
teristics, an inflammatory response does appear to be
present in wisping stage regenerates (n = 5; Figure 7A,
B, B’). Figure 7B’ highlights some of the more obvious
examples of lymphocytes and monocytes that are pre-
sent at this stage. These types of cells are associated
with the fibrin clot that forms in the injury site and can
be identified as early as one week after injury (Addi-
tional file 17A, B-B”).
To confirm the presence of various types of inflamma-
tory cells, we again tried several cell-type specific anti-
bodies, but these did not produce a reliable signal in
our preparations (Additional file 13). We were, however,
able to identify many phagocytic cells, or functional
macrophages, in the region of regenerating axons in our
EM images. Asterisks in Figures 5E and 7C mark
obvious macrophages. These macrophages could even
be seen to be in direct contact with axons (Figure 7D).
Figure 7E shows another example of a meningeal-like
cell process that is closely associated with regenerating
axons as well as ECM.
These data demonstrate that an inflammatory
response does appear to be present in the injured newt
spinal cord, but does not appear to be detrimental to
the regenerative response. In fact, one of the most
severe cases of inflammation was seen in a contact stage
regenerate (Additional file 17C,C’). The inflammation,
which was likely present at earlier stages as well, did not
prevent regeneration from progressing to this advanced
stage. The interaction of newt macrophages with axons,
if it also causes axon retraction in newts, does not pre-
vent the net response to be that of axon growth. Per-
haps the beneficial effects the immune system can have
on regeneration [33] outweigh any detrimental effects in
the newt.
Conclusions
Axons appear to be able to regenerate after an SCI in
the newt in part because the environment of the injury
site is not inhibitory. Instead of forming a dense inhi-
bitory scar and interacting to form a glia limitans and
as they do in mammals [2,9,10], newt meningeal cells
and glia appear to create a permissive environment for
axon regeneration. Figure 8 summarizes the stages of
axon regeneration and the roles these cell types play.
After an SCI, axons initially retract from the end of
the cut cord and appear dystrophic, but then initiate
growth by about 1 week. Axons wrap around the end
of the TV before growing into the lesion, perhaps
because meningeal cells create a transient basal lamina.
Meningeal and endothelial cells lead the way across the
lesion and are associated with a loose extracellular
matrix that permits growth cone migration. Axons
g r o wi n t ot h ei n j u r ys i t en e x ta n da r ec l o s e l ya s s o -
ciated with meningeal cells and glial processes that
extend from EG and astrocytic cell bodies surrounding
the central canal. Later in the process, ependymal
tubes lined with glia extend into the lesion as well.
Then, as a unit, meningeal cells, axons, and glia close
the gap in the spinal cord. Finally, axons enter the
cord on the opposite side of the injury and travel
through white matter to reach functional targets. We
also noted that though ascending axons do regenerate,
sensory axons do not appear to be among them and
that, overall, this regenerative process can occur in the
presence of an inflammatory response.
Model
Based on our observations, we propose a glia-meningeal
cell interaction model of spinal cord regeneration: spinal
cord regeneration is enabled when meningeal cells and
g l i a( a s t r o c y t e sa n dE G )i n t e r a c tt of o r mac o n d u i tf o r
axon regeneration rather than an inhibitory barrier
(scar, glia limitans, and dense ECM). Simpson [34]
hypothesized that successful spinal cord regeneration
depends upon an interaction between mesenchymal
cells and the ependymal epithelium that stimulates the
ependyma to proliferate and form a scaffold, which
guides axons across the lesion. Since astrocytes also
appear to be an important component in this interac-
tion, we have included astrocytes with the ependymal
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blastemal cells are the important mesenchymal cell after
tail amputation, but was not specific about which cells
play that role after SCI. We suggest that meningeal cells
are an important mesenchymal cell after SCI and that
they, too, can provide a scaffold for axon growth and
guidance.
Glia
Our model of spinal cord regeneration after an SCI is
similar to that after tail amputation in that EG play a
central role. Their processes are closely associated with
regenerating axons and may provide a substratum for
growth cone migration and guidance via cell-cell adhe-
sion. Our data also suggest that astrocytes may play a
Figure 7 An inflammatory response is present but not detrimental to axon regeneration. (A) Longitudinal section through a wisping
stage regenerate. Axons were labeled with 3A10 (magenta), nuclei are in blue, and fluorescent channels were laid over the phase image. (B) A
section adjacent to (A) stained with H&E. Many small cells with dark blue nuclei are present near wisping axons. (B’) Enlargement of blue box in
(B). Lymphocytes (arrowhead) and monocytes (arrows) can be identified near wisping axons. (C-E) Longitudinal section through a wisping stage
regenerate imaged with EM. (C) Region containing axons regenerating into the injury site. Many phagocytic cells (asterisks), or macrophages, can
be identified near regenerating axons. (D) Enlargement of box D in (C). Processes from this macrophage (m) are in direct contact with
regenerating axons (ax). (E) Enlargement of box E in (C). Another example of a meningeal cell-like process (p) that is mingled and closely
associated with regenerating axons (ax). ecm, ECM; R, rostral; C, caudal. Scale bars: 200 μm (A, B); 50 μm( B ’,C); 5 μm (D); 1 μm (E).
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dants of EG and not the fully mature astrocytes seen in
the mammalian spinal cord [35], and this may explain,
in part, why they respond so differently to SCI. The
arrangement of the glial processes, however, is different
from the tail regeneration model, at least initially.
Instead of extending radially from a pre-formed ependy-
mal tube to form channels through which axons can
grow [3], they extend longitudinally ahead of the TV
and run roughly parallel to the regenerating axons.
Such glial support may allow the axons to grow into
t h ei n j u r ys i t ei nt h ea b s e n c eo fap r e - f o r m e dt u b e .
They may also help guide the EG lining the central
canal, and thus the ependymal tube, into the region of
wisping axons, similar to the way in which radial pro-
cesses guide newborn neurons to their proper locations
in the developing cortex. Soma may translocate as their
processes shorten, or they may migrate along the pro-
cesses of other EG [36]. Given that very few cells in the
injury site express GFAP, we do not think many EG
undergo an epithelial to mesenchymal transition to
migrate freely into the lesion as proposed for axolotls
after SCI [7]. This does not rule out the possibility,
however, that undifferentiated progeny of EG might
migrate into the injury site. Alternatively, given that the
mesenchymal cells in the axolotl injury site were also
GFAP
- and were associated with FN, such cells could
be meningeal and/or endothelial cells.
Meningeal cells
Unlike most previous models of salamander spinal
cord regeneration, our model assigns an important role
to meningeal cells. Although they are thought to be
detrimental to axon regeneration in the injured
mammalian spinal cord, meningeal cells are able to sti-
mulate, support, and guide developmental and regen-
erative processes in other contexts. Meningeal cells are
fibroblast-like, and fibroblasts in flesh wounds are
responsible for remodeling the ECM into either scar or
normal tissue. The difference appears to depend on
whether the fibroblasts are stimulated by transforming
growth factor (TGF)b1o rT G F b3 [37]. As mentioned
previously, meningeal cells harvested from the olfac-
tory bulb, a part of the nervous system that does
regenerate, and transplanted into a mammalian SCI
along with OECs appear to fasciculate axons into peri-
neurial-like structures and enhance the ability of OECs
to remyelinate axons [28,29]. During development, the
meninges serve as substratum for and secrete a che-
moattractant, CXCL12, which regulates the migration
of Cajal-Retzius cells [38]. In the developing forebrain,
the meninges secrete retinoic acid, which stimulates
radial glia to begin producing neurons [39]. Meningeal
cells in mammalian SCI express retinoic acid and per-
missive ECM proteins, such as LM and FN [27,40].
Retinoic acid has been shown to stimulate and possibly
be an attractant for neurite outgrowth [41,42]. While
the permissive ECM proteins expressed by meningeal
cells in vitro tend to form a basal lamina that axons
cannot cross, axons appear to grow quite well along it
[40]. Thus, the basal lamina can either guide or inhibit
axon regeneration depending on its orientation. In
fact, following a large ablation of the spinal cord in
which the meninges were left intact, axons were seen
regenerating along the basal lamina of the meninges,
which was oriented in a productive direction parallel
to axon regrowth [6].
Axons
Our model does not exclude the possibility that axons
and axon intrinsic properties also play an important role
in newt spinal cord regeneration. The 1 week required
for growth initiation suggests that an intrinsic growth
Figure 8 Cellular model of newt axon regeneration. Schematics
of longitudinal sections through the spinal cord are shown. See text
for details. et, ependymal tube.
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a 1-week conditioning lesion encouraged neurite out-
growth from newt retinal explants [43]. Activation of
intrinsic growth could also enable axons to overcome
any inhibition CSPGs might inflict, similar to the way in
which embryonic neurons adapt to CSPGs [44,45].
Furthermore, matrix metalloproteinases are upregulated
during newt spinal cord regeneration (unpublished
observations), and if they are expressed in growth cones,
they could breakdown inhibitory ECM molecules and
allow the axons to grow through regions that would
normally be non-permissive. Axons may also directly
influence the behavior of the cells in their environment.
Nerves are required for newt limb regeneration, and
they stimulate Schwann cells to produce anterior gradi-
ent protein, a factor that is sufficient to rescue regenera-
tion in de-nervated limbs [46]. Regenerating optic nerve
axons in the frog appear to stimulate a breakdown of
the blood brain barrier at the front of regenerating
axons [47]. Finally, when degenerated optic nerve frag-
ments containing hypertrophic astrocytes are implanted
into an optic nerve injury site in frogs, axons grow into
the grafted tissue and appear to stimulate the reactive
astrocytes to adopt a more permissive architecture: the
astrocytes extend radial processes and form compart-
ments for axon elongation [48]. Thus, newt axons may
play a role in stimulating appropriate glial and menin-
geal cell responses.
If meningeal cells and glia support the development
and regeneration of the nervous system in some con-
texts, why do they not do so in all contexts? Although
no definitive answer can be put forward, we suspect
that the state of differentiation of the cells may play a
key role. In the newt spinal cord, EG maintain charac-
teristics of radial glia of the developing cortex [49],
astrocytes may be recent progeny of EG [35], and
many differentiated cells have the ability to dediffer-
entiate and become more progenitor-like [50]. An
exciting new study in mouse suggests that mammalian
glia, and possibly mammalian meningeal cells, may
retain the capacity to respond to an SCI in ways that
support axon regeneration. When the tumor suppres-
sor gene PTEN (phosphatase and tensin homolog) is
deleted in mouse corticospinal neurons, the neurons
are able to regenerate axons across an SCI, and their
axons cross the injury site in close association with
GFAP
+ cells and cell processes [51]. These GFAP
+
bridges tended to appear around the edges of the
spinal cord, the regions that are closest to the
meninges. Learning more about how newt cell types
are intrinsically different from their mammalian coun-
terparts and what factors stimulate newt cell types to
respond and interact in ways that promote axon regen-
eration may help us develop methods to cultivate
similar behaviors in mammalian cells. Identifying effec-
tive treatments for spinal cord injury in mammals has
been so intractable that it is imperative we take full
advantage of the opportunity to learn how nature has
already solved this problem in newts.
Materials and methods
Animals
Adult newts, N. viridescens, were purchased from
Charles D Sullivan Co. Inc. (Nashville, TN, USA),
housed at 22°C in glass aquariums equipped with water
filters, and fed live blackworms, Lumbriculus varietgatus
(Eastern Aquatics, Lancaster, PA, USA). All animal pro-
tocols were approved by the University of Utah Institu-
tional Animal Care and Use Committee.
Spinal cord injury
N e w t sw e r ea n e s t h e t i z e db ys u b m e r s i o ni n0 . 1 %T r i -
caine (ethyl 3-aminobenzoate methanesulfonate salt;
S i g m a ,S t .L o u i s ,M O ,U S A )i n2 0m MT r i s - H C l ,p H
7.5 for 10 minutes and placed in ice for 30 minutes
prior to surgery. Complete transection injuries were
performed similar to those described in Davis et al.
[1,12]. After swabbing the skin with 10% providone
iodine, a deep incision was made between vertebral
bones about 1 cm rostral to the hindlimbs. Using for-
ceps, the vertebrae were gently and slightly separated
and the dorsal lamina of the caudal vertebra was
removed to expose the spinal cord. The spinal cord
was cut completely with fine spring scissors. The com-
pleteness of the transection was easily verified by visual
inspection (Figure 1C). Blood was irrigated with sterile
85% PBS when necessary. Animals were kept moist
during the procedure, placed on ice for 15 minutes
after the surgery, and allowed to recover in bins that
were tilted to produce a shallow area of water. Bins
were cleaned and filled with fresh de-chlorinated water
every day or every other day throughout the recovery
period.
Axon tracer application
Our procedure was modified from that used in zebra-
fish [15,16]. Three axon tracers were tried: BDA (3
kDa, lysine fixable, Invitrogen, Carlsbad, CA, USA,
D7135), RDA (3 kDa, lysine fixable, Invitrogen,
D3308), and biocytin (Pierce, Rockford, IL, USA,
#28022). RDA appeared to work as well as BDA, but
was only used when two tracers were needed in the
same animal. Biocytin, which was reported to reveal
thin processes better than a 10 kDa RDA [15], unfor-
tunately did not produce a signal in our preparations,
perhaps because of the decalcification step in tissue
processing (see below). BDA and RDA were prepared
similarly: small pieces of gel foam (Pharmacia and
Zukor et al. Neural Development 2011, 6:1
http://www.neuraldevelopment.com/content/6/1/1
Page 16 of 22Upjohn Co., Kalamazoo, MI, USA) were soaked in 1.5
μl of a 10% solution and allowed to air dry 40 minutes
in a tissue culture hood to further concentrate the
solution. Fast green dye (Fisher, Waltham, MA, USA,
F - 9 9 )w a sa d d e dt ot h eB D As o l u t i o na t0 . 0 5m g / m l
to make it visible in vivo. Biocytin did not readily go
into solution at 10%, but a slurry was made. Small
pieces of gel foam were soaked in 10 μl of the slurry,
air dried completely, and stored at -20°C. To apply
tracer to the spinal cord, the cord was transected one
vertebral segment (about 2 mm) rostral or caudal to
t h eo r i g i n a li n j u r ys i t eu s i n gt h es a m ep r o c e d u r e
described above and a piece of gel foam saturated
with tracer was inserted into the gap. To apply tracer
to the sciatic nerve, an incision was made along the
course of the sciatic blood vessel on the posterior
aspect of the hindlimb where the hindlimb joins with
the body. Fine forceps were used to tease the nerve
from the vessel, and the nerve was transected with
fine spring scissors. A piece of gel foam saturated with
tracer was applied and the wound was sealed closed
with Vetbond tissue adhesive (3M, St. Paul, MN,
USA). Excessive bleeding was controlled before tracer
application, if necessary, by inserting a piece of gel
foam into the wound and allowing the animal to sit
on ice for several minutes. Use of this technique was
minimized, however, because it decreased the effi-
ciency of tracer uptake.
Tissue harvest, fixation, and decalcification
Animals were anesthetized as above, placed on ice for
at least 15 minutes, then perfused with about 1.5 ml
85% PBS followed by 3 ml periodate-lysine-parafor-
maldehyde (PFA) fixative (PLP: 75 mM lysine, 10 mM
sodium periodate, 0.5% PFA in 85% PBS, pH 7.4; 0.1
M lysine and 2% PFA stocks were stored at -20°C and
ingredients were mixed and used within 2 hours) [52].
All incubations were performed rocking at room
temperature (RT) and rinses were for 20 to 30 min-
utes, three times, unless otherwise specified. The
spinal column was harvested in about 4 mm long seg-
ments, post-fixed in PLP for 2 hours, rinsed with PBS
(137 mM NaCl, 2.7 mM KCl, 8.1 mM Na2HPO4,1 . 1 5
mM KH2PO4, pH 7.4), rinsed in fresh PBS overnight
at 4°C, decalcified with Morse’s solution (22.5% formic
acid, 10% sodium citrate) for 24 hours, and rinsed
with PBS. Some of the spinal cords prepared for paraf-
fin sections were not perfusion fixed and this did not
seem to affect the results, though perfusion did make
tissue prepared for thick and frozen sections easier to
section. An alternative fixative, 4% PFA, was tried, but
the quality of sections was not improved, there was
more autofluorescence, and some antibodies did not
work as well.
Thick sections and fluorescent labeling (spinal cord
whole-mounts)
Methods were adapted from previous studies [53,54]
and described in Zukor et al. [55]. All incubations
were performed rocking at RT unless otherwise speci-
fied. Decalcified tissue was bleached with formamide
bleach (6% hydrogen peroxide, 3% formamide, 0.1%
Triton X-100 in PBS) for about 2 hours; rinsed with
PBS for 20 to 30 minutes, three times; and embedded
in 4% agarose. Longitudinal sections containing the
whole spinal cord (about 350 μmt h i c k )w e r ec u to na
vibratome and collected in ice cold PBS. Sections were
transferred to 0.67 ml centrifuge tubes, permeabilized
with PBS-TxD (PBS containing 0.5 to 2% Triton X-
100 and 20% DMSO; 0.5% Triton X-100 was sufficient
for streptavidin, 2% was necessary for antibodies)
overnight and incubated in streptavidin or primary
antibody diluted in PBS-TxDB (PBS-TxD containing
1% BSA (EMD, Gibbstown, NJ, USA, #2960) and 0.1%
fish skin gelatin (Sigma, G7765) as blocking reagents)
for 7 days for streptavidin or 10 days for antibody
penetration. Sections needing incubation with second-
ary antibodies were rinsed with PBS-Tx (PBS with 2%
Triton X-100) for 30 minutes, five times and incu-
bated in secondary antibody diluted in PBS-TxDB for
10 days. Sections were then rinsed in PBS for 30 min-
utes, four times; rinsed in TNT (100 mM Tris-HCl,
pH 7.5, 150 mM NaCl, 0.05% Tween-20) for 30 min-
utes; incubated in SYTOX green (Invitrogen, S7020)
diluted 1/1,000 in DMSO, then 1/25 in TNT for 3
hours to stain nuclei; and rinsed in TN (TNT without
Tween-20) for 10 minutes, three times. Sections were
transferred to glass vials, dehydrated through a metha-
n o l( M e O H ) / T Ns e r i e s( 2 0 % ,5 0 % ,7 5 % ,1 0 0 %M e O H ;
15 minutes each); and cleared in BABB (1 part benzyl
alcohol, 2 parts benzyl benzoate) overnight at 4°C (not
rocking).
Frozen sections
Frozen sections of the injured spinal cord were difficult
to obtain presumably because it contains more water
than the intact cord and because the spinal column con-
tains tissues of heterogeneous density: the muscle and
bone are rigid and dense, while the spinal cord is quite
soft. Therefore, methods were adapted from Tokuyasu
[56]. Perfusion-fixed, decalcified tissue was cryopro-
tected to 2.3 M sucrose in PBS (3 hours in 25%, 3 hours
in 50%, overnight in 75%, 24 hours in 100% 2.3 M
sucrose; rocking and at RT) and frozen quickly in OCT
(Ted Pella, Redding, CA, USA, #27050) with liquid
nitrogen to minimize freezing artifacts. Sections 16 to
20 μm thick were obtained on a cryostat with the cham-
ber temperature set to -35°C and the object temperature
set to -34°C. For intact spinal cord, variables could be
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1.6 M sucrose and perfusion was not critical. Sections
were stored at -20°C and, prior to fluorescent labeling,
thawed, baked onto the slides for 1 hour at 50°C, and
rinsed in PBS for 5 minutes.
Paraffin sections
All incubations were performed with rocking at RT.
Decalcified tissue was dehydrated with ethanol (EtOH;
50% for 30 minutes, 70% for 30 minutes, 95% for 30
minutes, 100% for 30 minutes, 100% for 1 hour), infil-
trated (75% Hemo-De in EtOH for 20 minutes, 100%
Hemo-De for 1 hour, paraffin for 1 hour at 60°C and
15 Hg vacuum), and embedded in paraffin. Sections 10
to 20 μm thick were mounted onto slides, left on a 37°C
slide warmer overnight, and stored at 4°C. Prior to
fluorescent labeling or staining, sections were dewaxed
(Hemo-De for 10 minutes, 2 times; 75% Hemo-De in
EtOH for 5 minutes; 100% EtOH briefly and then for 3
minutes) and rehydrated (95% EtOH for 3 minutes, 70%
EtOH for 3 minutes, PBS or water for 5 minutes; PBS
was used for fluorescent labeling and water was used for
staining).
H&E staining
Paraffin sections rehydrated in water were stained:
hematoxylin (Harris modified, with acetic acid; Fisher,
W a l t h a m ,M A ,U S A ,S H 2 6 - 5 0 0 D )4m i n u t e s ,r u n n i n g
tap water 5 minutes, 70% EtOH briefly, acidified 70%
EtOH (10 drops of concentrated HCl to 200 ml 70%
EtOH) 1.5 minutes, bluing solution (10 drops of
NH4OH in 200 ml EtOH) 1 minute, Scott’ss o l u t i o n
(1 g sodium bicarbonate, 10 g magnesium sulfate in
500 ml water) 3 minutes, running tap water 5 minutes,
70% EtOH briefly, 0.1% Eosin in 95% EtOH (made
from 0.5% Eosin Y Solution, Sigma HT110-1-32) 1
minute, 95% EtOH briefly, 100% EtOH 5 minutes, 75%
Hemo-De in EtOH 5 minutes, 100% Hemo-De 5
minutes. Coverslips were mounted with Cytoseal 60
(Fisher, 23-244-256).
Fluorescent labeling in paraffin or frozen sections
Sections were blocked in PBS-TxB (PBS with 0.2%
Triton X-100, 1% BSA and 0.1% fish skin gelatin) for
1 hour; incubated with primary antibody diluted in
PBS-Tx (PBS with 0.2% Triton X-100) overnight at
RT; rinsed with PBS for 10 minutes, three times;
incubated with secondary antibody or streptavidin
diluted in PBS-Tx for 4 hours; rinsed with PBS for
10 minutes, two times; rinsed with TNT or TN for
10 minutes; incubated with SYTOX green (Invitrogen,
S7020) diluted 1/1,000 in DMSO, then 1/50 in TNT
or Hoechst 33342 (Invitrogen, A10027) diluted
1/2,000 in TNT for 30 minutes to stain nuclei; rinsed
in TN for 10 minutes, 50% TN for 10 minutes, and
water for 10 minutes. Coverslips were mounted with
Fluoromount G (Fisher, OB100-01) and sealed with
clear nail polish. For some experiments on paraffin
sections, incubation with primary antibody was
extended to 2 or 3 days at RT. This improved signal
without adding noise. Sections treated with chondroi-
tinase ABC (chABC) were treated before the blocking
step. They were equilibrated in tris acetate buffer
(50 mM Tris-HCl, pH 8.5, 60 mM sodium acetate,
0 . 0 2 %B S A ,0 . 5 %T r i t o nX - 1 0 0 ;m a d ef r e s h ,p H8 . 0 )
for 5 minutes, treated with chABC solution (7.5 U/ml
chABC stock diluted 1:50 in tris acetate buffer; stock
was chABC, Sigma C2905, EC 4.2.2.4, reconstituted
in 0.01% BSA) for 1 hour at 37°C, and rinsed with
PBS for 5 minutes, three times.
Antibodies and streptavidins
Primary antibodies and dilutions used are listed in
Table 2. Additional primary antibodies that were tried
are listed in Additional file 13. Secondary antibodies
(Invitrogen, whole antibodies, 2 mg/ml, conjugated to
Table 2 Table of antibodies
Antigen Antibody type Company, catalogue number Dilution, format
CSPGs (chick) Mouse IgM mAb Sigma, C8035 (CS-56) 1/100, ascites
Tenascin-C (chick) Rabbit pAb Chemicon, AB19013 1/100, concentrate
Tenascin-C (newt) Mouse IgM mAb DSHB, MT1 1/25, concentrate
Fibronectin (newt) Mouse IgG mAb DSHB, MT4 1/50, concentrate
Collagen XII (newt) Mouse IgG1 mAb DSHB, MT2 1/50, concentrate
Laminin (mouse) Rabbit pAb Sigma, L9393 1/25, concentrate
Fibrin (human) Mouse IgG1 mAb ADI, 350 1/50, concentrate
Neurofilament associated protein (chick) Mouse IgG1 mAb DSHB, 3A10 1/50, supernatant
GFAP (cow) Rabbit pAb Dako, Z0334 1/200, concentrate
von Willebrand factor (human) Rabbit pAb Dako, A0082 1/400, concentrate
ADI, American Diagnostica Inc.; DHSB, Developmental Studies Hybridoma Bank; mAb, monoclonal antibody; pAb, polyclonal antibody.
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Page 18 of 22Alexa 488, 568, 594, or 633) were diluted 1/100. Strep-
tavidin-Cy5 (Invitrogen, SA1011) and Streptavidin-Alexa
633 (Invitrogen, S21375) were diluted to 4 μg/ml. The
FN and Col XII antibodies and one TN-C antibody are
newt-specific and have been characterized [57-59].
The non-newt-specific antibodies appear to be specific
in that they produced appropriate expression patterns
and are specific in western blots (not shown, not done
for vWF and CSPG antibodies). The specificity of the
CSPG antibody was verified by treating adjacent sec-
tions with chABC and incubating them with the CSPG
antibody. The specificity of the secondary antibodies
was verified by treating adjacent sections with second-
a r ya n t i b o d i e si nt h ea b s e n c eo fp r i m a r ya n t i b o d i e s .
Very little non-specific signal was seen in either case
(Figure 4W,X), and what little was seen tended to
appear in the white matter. The chick-specific TN-C
antibody produced an expression pattern similar to
the newt-specific antibody, but its signal was much
stronger and so it was used instead. The antibody
against Col XII was used to approximate the expres-
sion of Col I since it is found in association with Col I
and may enhance the stability of the ECM by bridging
collagen fibrils [60,61]. Since paraffin processing may
affect CS-56 labeling, CSPGs were analyzed in frozen
sections. TN-C, FN, LM, and Col were analyzed in
paraffin and frozen sections. Expression patterns were
also verified in whole-mount preparations (not
shown).
Confocal imaging and image processing
Sections labeled with fluorescent dyes were imaged on
an Olympus FV300 or FV1000 laser scanning confocal
microscope using a 10× or 20× air objective. Images
were processed with Image J, version 1.40 g [62] and
Adobe Photoshop CS2. Levels were adjusted in Photo-
shop to maximize the signal to noise ratio but the same
adjustments were made to experimental and control
images.
Preparation of tissue for electron microscopy
Methods were adapted from Anderson et al.[ 6 3 ] .A n i -
mals were anesthetized as above, then perfused with
about 1.5 ml 85% PBS followed by 3 ml EM fixative
(2.5% glutaraldehyde, 1% formaldehyde, 3% sucrose,
1m MM g S O 4 in 0.1 M cacodylate buffer (CB), pH
7.4). The spinal column was harvested in about 4 mm
long segments; post-fixed in EM fixative overnight at
RT; decalcified in cold EDTA solution (0.1 M EDTA,
pH 7.2 to 7.4 with 4% glutaraldehyde) for 4 days at 4°
C; rinsed in 0.1 M CB for 20 minutes, three times;
rinsed in PBS briefly; and embedded in 4% agarose.
Longitudinal sections containing the whole spinal cord
(about 350 μm thick) were cut on a vibratome and col-
lected in ice cold PBS. Sections were returned to 0.1 M
CB; osmicated (1% OsO4 i n0 . 1MC B )f o r1h o u r ;
rinsed in 0.1 M CB for 10 minutes, three times; par-
tially dehydrated (50%, 75% MeOH; 10 minutes each);
treated with 1% uranyl acetate in 75% MeOH for 1
hour; fully dehydrated (75%, 85%, 95%, 100%, 100%
MeOH; 10 minutes each); infiltrated with resin (100%
acetone 10 minutes, two times; 75% resin in acetone
overnight; 100% resin 1 hour); embedded in epoxy
resin (2 parts dodecenyl succinic anhydride (DDSA,
Ted Pella, 18022), 1 part eponate 12 resin (Ted Pella,
18005), 0.06 parts DMP30 accelerator (Ted Pella,
18042)) and cured at 60°C for 2 days. Sections were
re-embedded for longitudinal sectioning, and 80-nm
sections were collected onto carbon-coated Formvar
films in gold single-hole grids, stained with 5% uranyl
acetate for 1 hour and 1% lead citrate for 25 minutes,
and imaged at 80 KeV in a JEOL JEM 1400 electron
microscope at 5,000× magnification. Images were cap-
tured digitally on a GATAN Ultrascan 4000 16 mega-
pixel 16-bit camera and mosaicked with ir-tools [63].
Mosaics were viewed and selections were captured
with Viking software.
Additional material
Additional file 1: Movie 1: recovery of swimming function after
spinal cord transection injury. When an uninjured newt swims, it
propels itself forward by pressing its legs close to its side and undulating
its body in an S-shaped motion. When it is finished swimming, it brings
its legs forward again, perpendicular to its body axis. One day after a
complete transection injury, the hindlimbs are completely paralyzed. Four
weeks after injury, this same newt is still paralyzed. When it attempts to
swim, it does not use its hindlimbs at all. By 7 weeks, this newt has
recovered swimming function and swims similarly to an uninjured newt.
Additional file 2: Figure S1: the largest spinal nerves are associated
with the S1 and T-1 vertebrae. (A) Close-up view of S1, dorsal aspect.
The rib associated with this vertebra articulates with the ilium of the
pelvis to form the SI joint. (B) Ventral side of spinal column showing
vertebrae T-4 to S2/C1. The largest spinal nerves (arrowheads) are
associated with T-1 and S1. T-2 is intermediate in size. T-4, T-3 and S2/C1
are small. Dotted circles, approximate location of the spinal ganglia;
dotted lines, approximate course spinal nerves take to spinal ganglia.
Note that the actual location of the SCI in this animal is one segment
rostral (between T-5 and T-4) to the targeted site (between T-4 and T-3).
(C) Close-up of T-1 and S1 shown in (B). More flesh has been removed
to demonstrate that the vertebra associated with the caudal-most large
spinal nerve is indeed S1. The rib associated with it articulated with the
pelvis. R, rostral; C, caudal.
Additional file 3: Figure S2: retraction and growth initiation stage
images seen in z-projections. The difference between the retraction
and growth initiation stages is apparent throughout the whole spinal
cord and is not just a function of which z-plane was chosen for
presentation. (A-D) Images of retraction (A, B) and growth initiation (C,
D) shown in Figure 2. All are single confocal planes, except (B), which is
a z-projection of four planes. (A’-D’) Z-projections of all planes through
the spinal cord, showing just the axon tracer channel, for the same
animals in (A-D). In the retraction stage, fewer axons extend to the end
of the cut cord (arrowheads). R, rostral; C, caudal. Scale bars: 200 μm ((A-
D) are the same scale; (A’-D’) are the same scale).
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Page 19 of 22Additional file 4: Figure S3: size of gap in spinal cord at each stage.
Gap size increases before it decreases and is largest during the wrapping
stage. Dark lines, median; box, interquartile range (IQR, 25% to 75%);
whiskers, most extreme data point that is no more than 1.5 IQR from the
box; small circle, outlier. The size of the gap during the wrapping stage
is statistically different (asterisk) from that during the retraction stage,
with P < 0.001 (using Bonferroni correction for multiple t-tests).
Additional file 5: Movie 2: movie through confocal z-stack of animal
shown in Figure 5D, a wisping/spiking stage regenerate. The movie
begins on the ventral side of the cord and moves in 2-μm increments
through to the dorsal side. Rostral is up. Axons are labeled with 3A10 in
magenta, and nuclei are in green. Note the meninges appear to have
regenerated across the gap first and that some axons appear to have
followed these meninges.
Additional file 6: Movie 3: movie through confocal z-stack of animal
shown in Figure 2J, a spiking stage regenerate. The spike does not
contain an ependymal tube in this animal. The movie begins on the
ventral side of the cord and moves in 2-μm increments through to the
dorsal side. Rostral is up. Descending axons are labeled with the axon
tracer in magenta and nuclei are in green.
Additional file 7: Movie 4: movie through confocal z-stack of animal
shown in Figure 2I, a spiking stage regenerate. The spike does contain
an ependymal tube in this animal. The movie begins on the ventral side
of the cord and moves in 2-μm increments through to the dorsal side.
Rostral is up. Descending axons are labeled with the axon tracer in
magenta and nuclei are in green.
Additional file 8: Figure S4: sloppiness and misalignments in axon
regeneration. Axon regeneration has some tolerance for sloppiness, but
gross misalignments may result in a delay or failure to recover. All
images are montages of single confocal planes of longitudinal thick
sections, except (F) which is a cross-section. Axons in all images were
labeled with the axon tracer (magenta), and nuclei are green. (A-A”) A9 -
week regenerate in the growth beyond stage that had recovered
swimming function. The ependymal tubes have connected (A), some
axons appear to decussate (arrowhead in (A’)) and wrapping axons are
still evident (open arrowhead in (A”)). (B) A 4-week regenerate in the
growth beyond stage that had not recovered function. Similar to (A),
axons appear to wrap (open arrowhead) and decussate (arrowhead). (C)
A 9-week regenerate in the growth beyond stage that had not
recovered function. A long spike appears to have elongated from the
caudal side (dotted lines), and this may indicate that the gap in the cord
was large. (D) A 6-week regenerate in the spiking stage that had not
recovered function. The whole spike appears to be veering off in the
wrong direction and does not line up properly with the cord on the
other side (dotted lines). Arrow, dorsal root to the spinal ganglia. (E) A9 -
week regenerate in the growth beyond stage that had not recovered
function. Two ependymal tubes (fat arrows) appear to have formed on
the rostral side. (F) Cross-section through a 9-week regenerate in the
growth beyond stage that had not recovered function. Axon
regeneration appears to be sloppy in that axons are wisping dorsally
towards the tissue wound that was created to gain access to the spinal
cord. R, rostral; C, caudal; D, dorsal; V, ventral. Scale bars: 500 μm ((A-E)
are the same scale); 200 μm (F).
Additional file 9: Movie 5: movie through confocal z-stack of animal
shown in Additional file 8 A-A”, a recovered animal. This is a 9-week
regenerate in the growth beyond stage that had recovered function. The
movie begins on the ventral side of the cord and moves in 2-μm
increments through to the dorsal side. Rostral is up. Descending axons
are labeled with the axon tracer in magenta and nuclei are in green.
Additional file 10: Movie 6: movie through confocal z-stack of
animal shown in Additional file 8E, a non-recovered animal. This is a
9-week regenerate in the growth beyond stage that had not recovered
function. It begins on the ventral side of the cord and moves in 2-μm
increments through to the dorsal side. Rostral is up. Descending axons
are labeled with the axon tracer in magenta and nuclei are in green.
Note there are two ependymal tubes on the rostral side.
Additional file 11: Table S1: Stages of 2.5- to 3-week regenerates
analyzed after initial study.
Additional file 12: Figure S5: a glia limitans-like structure may be
present during the wrapping stage. Longitudinal sections through
wrapping stage regenerates. Axons were labeled with the axon tracer in
(C, D) and are shown in magenta. Each ECM protein is shown in green,
and nuclei are blue. (A-D) Col XII (A), FN (B), and TN-C (C) expression
wraps around the end of the cord, while LM (D) expression does not. R,
rostral; C, caudal. Scale bar: 200 μm (A-D).
Additional file 13: Table S2: Table of other antibodies tested.
Additional file 14: Figure S6: meninges of the intact spinal cord.
Longitudinal section through the intact spinal cord imaged with EM. (A)
Region containing the meninges. p, pia mater; a, arachnoid mater; d,
dura mater; sas, subarachnoid space; ecm, ECM; ef, glial end feet; o,
oligodendrocyte. (B) Enlargement of box B in (A) showing skinny, dark
processes of dura mater cells (arrows) associated with collagen fibrils (c)
of the dura mater. (C) Enlargement of box C in (A) showing layers of
arachnoid cell processes (a), a skinny process from a dura mater cell
(arrow), and collagen (c). (D) Enlargement of box D in (A) showing a pia
mater cell. (E) Enlargement of box E in (A) showing neural collagen (nc).
(F) Enlargement of box F in (A) showing the basement membrane
(arrowhead) at the glia limitans of the spinal cord, collagen (c) and
neural collagen (nc). R, rostral; C, caudal. Scale bars: 15 μm (A); 3 μm (D);
1.5 μm (B, C, E, F).
Additional file 15: Figure S7: other cell types in the intact spinal
cord. Longitudinal section through the intact spinal cord imaged with
EM. (A) Region containing the central canal (cc), EG layer (EG) and a
portion of the grey mater (gm). (B) Enlargement of box B in (A) showing
astrocytes. (C) Enlargement of box C in (A) showing the cytoplasm of
light EG. (D) Enlargement of box D in (A) showing the cytoplasm of dark
EG. (E) A microglial cell. (F) An oligodendrocyte. R, rostral; C, caudal.
Scale bars: 15 μm (A, B, F); 5 μm (E); 3 μm (D); 1.5 μm (C).
Additional file 16: Figure S8: glia of the regenerating spinal cord.
(A-D) Longitudinal section through a wisping stage regenerate imaged
with EM. (A) Region containing axons wisping ahead of the TV. (B)
Enlargement of box B in (A) showing a light glial process (EGL) that is
associated with regenerating axons (ax). (C) Enlargement of box C in (A)
showing light (EGL) and dark (EGD) EG lining the TV. (D) Enlargement of
box D in (A) showing a dark EG process (EGD) associated with axons (ax).
R, rostral; C, caudal. Scale bars: 50 μm (A); 15 μm (C); 5 μm (B); 3 μm (D).
Additional file 17: Figure S9: the inflammatory response in early
and late stage regenerates. (A,B) Adjacent longitudinal sections
through a 1-week regenerate labeled with an anti-fibrin antibody (A) and
stained with H&E (B). A fibrin clot is formed in the injury site (A), and
inflammatory cells can already be identified in this clot (B). (B’,B”)
Enlargement of primed and double primed boxes in (B). Lymphocytes
(arrowheads in (B’)) and monocytes (arrow in (B”)) can be identified.
Asterisk, fibrin clot. (C) Longitudinal section through a contact stage
regenerate. A relatively strong inflammatory response has not prevented
this animal from progressing to this late stage. (C’) Enlargement of box
in (C). Lymphocytes (arrowhead) and monocytes (arrows) can be
identified. R, rostral; C, caudal. Scale bars: 200 μm (A; (B,C) are the same
scale); 50 μm ((B’,B”) are the same scale; C’).
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